Larry Cheung

Letters from Larry: U.S. and China Investment Strategy

About Larry

Larry Cheung, CFA is the founder of a leading Substack publication named Letters of Larry: U.S. and China Investment Strategy. He is also a Youtube creator with over 100,000+ followers and has a research focus on US and China macroeconomics, financial markets, and company-specific fundamental analysis. As a chartered financial analyst, he is passionate about helping his followers grow their wealth through long-term investing and thoughtful tactical trading. He can be found as @LarryCheungCFA on Twitter, Instagram, Youtube, and Substack.

Larry's Articles

View All Articles

TER: What Earnings and the Market Reaction Say About the Semiconductor Sector

Throughout 2024, Teradyne Inc. (TER) has been a large beneficiary of rising revenue and EBITDA estimates across the entire semiconductor sector. With the semi industry and Big Tech seeing a very harsh selloff, I’m inclined to think that risk/reward has improved for long-focused investors, advises Larry Cheung, founder of Letters from Larry.

Larry Cheung

TECHNOLOGY

Tickers: MU, QCOM, SOXX, TXN, TER

SOXX: Showing Strength in a "Big Tech"-Led Market

Several major Big Tech companies are reporting this week. I believe that as long as they continue discussing “cost-cutting” initiatives and keep margins elevated, any big dips are likely to be bought. The strongest sector in the market is currently Semiconductors, viewed through the lens of the iShares PHLX SOX Semiconductor ETF (SOXX), writes Larry Cheung, founder of Letters from Larry.

Larry Cheung

TECHNOLOGY

Tickers: QQQ, SOXX

Top Picks 2024: Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ), a globally recognized leader in healthcare, presents a compelling value investment proposition due to its diversified presence across major healthcare industries. As the world's largest and most diverse healthcare firm, JNJ's operations span pharmaceuticals, medical devices, and consumer healthcare products, counsels Larry Cheung, founder of Letters from Larry.

Larry Cheung

HEALTHCARE

Tickers: JNJ

Top Picks 2024: Oracle (ORCL)

Oracle (ORCL) is a leader in on-premises relational database technologies and enterprise resource planning (ERP) software. With its strong customer base and technological expertise, Oracle aims to capitalize on cloud opportunities and strategic partnerships, like with Microsoft, to bolster its position against giants like Amazon, suggests Larry Cheung, founder of Letters from Larry.

Larry Cheung

TECHNOLOGY

Tickers: ORCL

Larry's Videos

The 2024 Investment Outlook on U.S. & Hang Seng Stocks

In this webinar, Larry Cheung, CFA will discuss his outlook on both the S&P 500 and the Hang Seng Index, with a particular focus on companies that have high dependence on China's macroeconomic landscape. This means that key retail names within the SPX as well as Semiconductors will be in focus. The U.S. market is coming off one of the best years in the past decade while China's Hang Seng Index is the world's worst-performing market in all of 2023. Will these trends persist into 2024? We will discuss the fundamentals, valuation, and technical setup of both markets in this presentation.

Larry Cheung

GLOBAL

34:11